Efficacy and safety of 2-hour urokinase regime in acute pulmonary embolism: a randomized controlled trial

BACKGROUNDS: Urokinase (UK) 2 200 U/kg·h for 12 hours infusion(UK-12 h)is an ACCP recommended regimen in treating acute pulmonary embolism (PE). It is unclear whether this dose and time can be reduced further. We compared the efficacy and safety of 20, 000 U/kg for 2 hours (UK-2 h) with the UK-12 h...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Chen, Zhai, Zhenguo, Yang, Yuanhua, Yuan, Yadong, Cheng, Zhaozhong, Liang, Lirong, Dai, Huaping, Huang, Kewu, Lu, Weixuan, Zhang, Zhonghe, Cheng, Xiansheng, Shen, Ying H
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2806365/
https://www.ncbi.nlm.nih.gov/pubmed/20040086
http://dx.doi.org/10.1186/1465-9921-10-128

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2806365/
https://www.ncbi.nlm.nih.gov/pubmed/20040086
http://dx.doi.org/10.1186/1465-9921-10-128

Ejemplares similares